1. Superficial expression, including the effective amount of paraoctanol preparation, such as carp or acceptable salt, and one or more adrenaline allergy or antipharmace1. Eye design may help in the treatment of diseases, such as stress disorders, that have an adverse effect on the patient's vision. A method of visual expression described for the treatment or improvement of stress symptoms. Page: 1 Claim 2: the surface expression in claim 1,2. Characteristics: Patients with one or more adrenaline strong drugs or p-sulfurizer A1 were selected as amphetamine, phenylalanine, acetamide, oxymethylbenzoate, xylidine, triazoline and acceptable pharmaceutical salts among these substances. Claim 3: a visual formulation according to claim 1, characterized in that it comprises adrenaline A1, i.e., an acceptable pharmaceutical salt in phenol or phenol. Claim 4: the surface expression in claim 3,It is characterized by a phenyl content of about 0.5% to 3% by weight. Claim 6: visual representation in line with any one of the claims in 1-5, which is characterized by carp weight accounting for about 0.1% to 0.7%. Item 8: eye formula meeting the requirements of item 7, which is characterized by that vasoconstractor is a pharmaceutically acceptable salt of namazine or contained in it. Claim 9: the ostensible expression according to claim 7,Because it also contains antihistamines 11. Claim 11: visual formula conforming to claim 9, characterized in that antihistamine is an acceptable pharmaceutical salt in phenylmethylamine or phenylethylamine. Claim 12: eye formula in accordance with claim 11, characterized by a phenyl content of approximately 0.03 to 0.09% by weight. Requirement 15: a visual formulation according to requirement 13, characterized by non steroidal anti-inflammatory drugs selected from the nepafenac and melody groups.Formulación oftálmica que comprende una cantidad eficaz de un agente parasimpatomimético que es la pilocarpina o una sal farmacéuticamente aceptable de ésta
